Methylprednisolone acetate Medicines in Ireland - 4 Licensed Products

Markets · 15 min delay

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

ISEQ9,241.3▲ +0.62%

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Showing 4 authorised medicines

Medicine	Active substance	Licence holder	Status
Depo-Medrone 40 mg/ml Suspension for Injection 1 ml vial PA0822/122/001	Methylprednisolone acetate	Pfizer Healthcare Ireland Unlimited Company	Marketed
Depo-Medrone 40 mg/ml Suspension for Injection 2 ml vial PA0822/122/002	Methylprednisolone acetate	Pfizer Healthcare Ireland Unlimited Company	Marketed
Depo-Medrone 40 mg/ml Suspension for Injection 3 ml vial PA0822/122/003	Methylprednisolone acetate	Pfizer Healthcare Ireland Unlimited Company	Marketed
Depo-Medrone 40mg/ml with Lidocaine 10mg/ml Suspension for Injection, 2ml vial PA0822/123/002	Methylprednisolone acetate, Lidocaine hydrochloride	Pfizer Healthcare Ireland Unlimited Company	Marketed

Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 5 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.

Methylprednisolone acetate - Medicines in Ireland